185
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting – Part I: In vitro Release and Intracellular Uptake Perspective

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & show all
Pages 8845-8862 | Published online: 10 Nov 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Anis Askarizadeh, Mohammad Mashreghi, Elaheh Mirhadi, Amin Mehrabian, Vahid Heravi Shargh, Ali Badiee, Seyedeh Hoda Alavizadeh, Leila Arabi, Hossein Kamali & Mahmoud Reza Jaafari. (2023) Surface-modified cationic liposomes with a matrix metalloproteinase-degradable polyethylene glycol derivative improved doxorubicin delivery in murine colon cancer. Journal of Liposome Research 0:0, pages 1-18.
Read now
Yasmeen Ezzeldeen, Shady Swidan, Aliaa ElMeshad & Aya Sebak. (2021) Green Synthesized Honokiol Transfersomes Relieve the Immunosuppressive and Stem-Like Cell Characteristics of the Aggressive B16F10 Melanoma. International Journal of Nanomedicine 16, pages 5693-5712.
Read now
Aya Ahmed Sebak, Iman Emam Omar Gomaa, Aliaa Nabil ElMeshad, Mahmoud Hussien Farag, Ulrike Breitinger, Hans-Georg Breitinger & Mahmoud Hashem AbdelKader. (2020) Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting – Part II: In vitro and in vivo Kinetics Study. International Journal of Nanomedicine 15, pages 9539-9556.
Read now

Articles from other publishers (9)

Ruoyu Shen & Hong Yuan. (2023) Achievements and Bottlenecks of PEGylation in Nano-delivery Systems. Current Medicinal Chemistry 30:12, pages 1386-1405.
Crossref
Elena Boggio, Casimiro Luca Gigliotti, Ian Stoppa, Deepika Pantham, Sara Sacchetti, Roberta Rolla, Margherita Grattarola, Chiara Monge, Stefania Pizzimenti, Umberto Dianzani, Chiara Dianzani & Luigi Battaglia. (2023) Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications. Pharmaceutics 15:3, pages 937.
Crossref
Asmaa Ramzy, Sara ElSafy, Hisham A Elshoky, Aya Soliman, Rana Youness, Samar Mansour & Aya Sebak. (2022) Drugless nanoparticles tune-up an array of intertwined pathways contributing to immune checkpoint signaling and metabolic reprogramming in triple-negative breast cancer. Biomedical Materials 18:1, pages 015023.
Crossref
Woojun Kim, Nhu Ky Ly, Yanying He, Yongzhe Li, Zhongyue Yuan & Yoon Yeo. (2023) Protein corona: Friend or foe? Co-opting serum proteins for nanoparticle delivery. Advanced Drug Delivery Reviews 192, pages 114635.
Crossref
Karin Nienhaus, Yumeng Xue, Li Shang & Gerd Ulrich Nienhaus. (2022) Protein adsorption onto nanomaterials engineered for theranostic applications. Nanotechnology 33:26, pages 262001.
Crossref
Xiaobo Wang & Wenli Zhang. (2022) The Janus of Protein Corona on nanoparticles for tumor targeting, immunotherapy and diagnosis. Journal of Controlled Release 345, pages 832-850.
Crossref
Zhe Cheng, Maoyu Li, Raja Dey & Yongheng Chen. (2021) Nanomaterials for cancer therapy: current progress and perspectives. Journal of Hematology & Oncology 14:1.
Crossref
Shreelaxmi Gavas, Sameer Quazi & Tomasz M. Karpiński. (2021) Nanoparticles for Cancer Therapy: Current Progress and Challenges. Nanoscale Research Letters 16:1.
Crossref
Md Habban Akhter, Habibullah Khalilullah, Manish Gupta, Mohamed A. Alfaleh, Nabil A. Alhakamy, Yassine Riadi & Shadab Md. (2021) Impact of Protein Corona on the Biological Identity of Nanomedicine: Understanding the Fate of Nanomaterials in the Biological Milieu. Biomedicines 9:10, pages 1496.
Crossref